After a standard 2 mg Eylea injection, the drug remains active inside your eye for roughly 8 to 9 weeks, with a half-life of about 9 days in the vitreous fluid. A small amount leaks into your bloodstream, where it circulates with a half-life of roughly 5 to 11 days before being broken down. In practical terms, the drug is functionally cleared from your body within about 6 to 8 weeks after a single injection, though trace amounts may linger slightly longer.
Those timelines shift significantly if you’re receiving the newer 8 mg (Eylea HD) formulation, which was designed to last longer between injections. Here’s how both versions work their way through your system.
How Long Eylea Lasts in the Eye
Eylea is injected directly into the vitreous, the gel-like fluid that fills the back of your eye. Once there, it binds to a growth factor called VEGF that drives abnormal blood vessel leakage in conditions like wet macular degeneration and diabetic eye disease. The drug’s half-life inside the eye is estimated at about 9 days, meaning half the original dose is still present after that time, a quarter remains after 18 days, and so on.
For the standard 2 mg dose, free drug remains at effective levels in the eye for approximately 8 to 9 weeks. That’s why most patients on the 2 mg formulation receive injections every 8 weeks after an initial loading phase. By that point, VEGF suppression starts to fade and fluid can begin leaking again.
The 8 mg Eylea HD formulation clears about 34% more slowly from the eye and has a roughly 1.5 times longer ocular half-life than the 2 mg dose. According to FDA review data, the median time for free drug to fall below effective levels increases from about 8.7 weeks with the 2 mg dose to 15 weeks with the 8 mg dose. That extra six weeks of coverage is why Eylea HD can be dosed every 12 to 16 weeks for many patients, with some extending to every 24 weeks after the first year.
How Long It Stays in Your Bloodstream
Only a tiny fraction of each Eylea injection escapes the eye and enters your blood. Peak plasma levels after a 2 mg injection are typically 20 to 50 nanograms per milliliter, which is more than 100 times lower than the concentration needed to significantly block VEGF throughout your whole body. Once in the bloodstream, the drug’s systemic half-life has been measured at roughly 5 to 11 days, depending on the study and patient population.
Using the longer estimate of about 11 days, it takes roughly five half-lives for a substance to be essentially undetectable. That puts full systemic clearance at around 8 weeks. With the shorter half-life estimate, clearance could happen in as little as 4 weeks. For most people, Eylea is effectively gone from the bloodstream well before their next scheduled injection.
How Your Body Breaks It Down
Eylea (aflibercept) is a protein, so your body eliminates it the same way it handles other proteins: by breaking it apart into amino acids through normal metabolic processes. There’s no special burden on your liver or kidneys the way there would be with a traditional drug that needs to be processed and filtered out.
The drug also disappears through a second pathway called target-mediated clearance. As Eylea molecules circulate, they latch onto free VEGF in the bloodstream, forming inactive complexes that are then naturally cleared. This means part of the drug is essentially used up by doing its job.
Because elimination relies on general protein metabolism rather than liver or kidney function, there’s no indication that impaired organ function meaningfully changes how long Eylea stays in your system.
Systemic Effects While the Drug Circulates
Even though plasma concentrations are low, Eylea does suppress VEGF levels in the blood to a measurable degree. In one study, a dramatic drop in plasma VEGF was detected as soon as 3 hours after the first injection and persisted for at least 7 days. After repeated monthly injections, systemic drug exposure increased further, with total blood exposure measured at about 13 times higher for Eylea than for ranibizumab (Lucentis), a smaller molecule that leaks less into the bloodstream.
For most patients, this low-level systemic VEGF suppression doesn’t cause noticeable problems. Large registration trials did not find a statistically significant increase in heart attacks, strokes, or deaths with Eylea compared to other anti-VEGF drugs. However, a closer look at one trial found that adults over 85 had a higher rate of stroke-like events with Eylea (about 7% at one year) compared to ranibizumab (about 1.2%). These studies were not large enough to draw firm conclusions about rare events, but the signal in very elderly patients is something doctors factor into treatment decisions.
Standard 2 mg vs. 8 mg HD: Duration at a Glance
- 2 mg (standard Eylea): Active in the eye for about 8 to 9 weeks. Cleared from the bloodstream within roughly 4 to 8 weeks. Typically dosed every 8 weeks after loading.
- 8 mg (Eylea HD): Active in the eye for up to 15 weeks. Modeling studies show it can suppress VEGF for up to 105 days (15 weeks) per injection. Approved for dosing intervals up to every 16 weeks, with some patients extending to 24 weeks after the first year.
What This Means Between Injections
If you’re wondering whether the drug is “still working” as your next appointment approaches, the answer depends on your dose and your individual response. With the standard 2 mg injection given every 8 weeks, the tail end of that interval is when drug levels are lowest and some patients notice a return of symptoms like blurry or wavy vision. This is sometimes called the “wearing off” effect, and it’s one reason doctors may switch patients to the 8 mg formulation or shorten intervals.
With Eylea HD at 8 mg, simulations show VEGF stays fully suppressed through 12 and even 15 weeks. At 16 weeks, some breakthrough VEGF activity was observed in models, which is why 16 weeks is generally the upper limit for dosing in the first year. Your doctor adjusts your specific interval based on how your eye responds on imaging, not just a fixed calendar.
If you’re having a medical procedure or starting a new medication and need to know whether Eylea is still in your body, the conservative assumption is that it takes roughly 2 months after your last injection for the standard dose to be fully cleared from both your eye and bloodstream.